Canada markets closed

ASLAN Pharmaceuticals Limited (ASLN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.4471-0.0194 (-4.16%)
At close: 04:00PM EDT
0.4600 +0.01 (+2.89%)
After hours: 06:08PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
12,000
12,000
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
12,000
12,000
0
0
0
Operating Expenses
Research Development
42,495
42,495
38,000
22,021
9,314
Selling General and Administrative
13,240
13,240
9,882
11,825
7,169
Total Operating Expenses
55,662
55,662
47,605
33,815
16,183
Operating Income or Loss
-43,662
-43,662
-47,605
-33,815
-16,183
Interest Expense
4,327
4,327
3,668
1,861
1,247
Total Other Income/Expenses Net
3,502
3,502
-451.485
4,085
458.437
Income Before Tax
-44,087
-44,087
-51,283
-31,591
-16,971
Income Tax Expense
132.667
132.667
99.221
0
0
Income from Continuing Operations
-44,220
-44,220
-51,382
-31,591
-16,971
Net Income
-44,220
-44,220
-51,382
-31,322
-16,198
Net Income available to common shareholders
-44,220
-44,220
-51,382
-31,322
-16,198
Basic EPS
-3.00
-2.75
-3.75
-2.50
-2.00
Diluted EPS
-3.00
-2.75
-3.75
-2.50
-2.00
Basic Average Shares
15,614
16,450
13,949
13,027
7,689
Diluted Average Shares
15,614
16,450
13,949
13,027
7,689